This study demonstrated that a linezolid PA program did not appear to be associated with a negative impact on medical outcomes and was associated with lower costs.
This paper considers opportunities and barriers relating to medication taking and self-management by people with diabetes and related conditions as discussed during an invitational symposium.
Specialty drug costs for 13 to 23 million patients in the United States would be $185 to 342 billion.
With national brand recognition and expert support, pharmacy franchise owners reach more patients.
Adherence to drug therapy in hepatitis C increased total costs in year 1 relative to nonadherent patients, then decreased total costs in year 2.
The second part of a comprehensive review of the specialty pharmaceuticals approved by the FDA in 2017.
Most notably, COVID-19 has transformed the landscape for medical science liaisons (MSLs) by forcing them to rapidly adapt to the present circumstances.
Half of millennial-aged men and women said they have never been tested for HIV outside of blood donation.
Current definitions attempting to summarize specialty pharmacy fall short.
As pharmacists administer more vaccines, the risks of needle-stick injury and transmission of a bloodborne disease increase among pharmacists.
Among rheumatoid arthritis patients newly treated with adalimumab, etanercept, or infliximab, lower dose escalation rates and costs were seen with etanercept.
Recently announced changes in vaccine reimbursement under Medicare have implications for pharmacy billing processes.
Biosimilars, which at the most simplistic level can be thought of as a type of generic option for a biologic, offer an opportunity to help reduce total biologic drug spend.
Mr. Mattingly is a third-year professional student in the PharmD Program at the University of Kentucky College of Pharmacy and is dually enrolled in the MBA Program at the Gatton College of Business and Economics.
New treatments with biological agents and vaccines are creating a pathway for patients with metastatic CRC.
Pharmacists can learn about current management of type 2 diabetes mellitus, including updated clinical practice guidelines and the incorporation of new therapeutic classes into practice recommendations.
Did you know that health plans completely cover certain OTC products when patients present a prescription?
There were no signifi cant differences in mean low-density lipoprotein cholesterol levels after patients were converted from fl uvastatin to pravastatin therapy.
The placement of clinical pharmacists at the nexus of functional pharmacogenomics and in specialty pharmacy care makes good sense.
Demonstrating success is critical to building a long-term care business. How can your pharmacy make a difference?
Gaining the most value from membership requires active participation by techs and a willingness to go outside their comfort zones.